WEHI-539

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Min.Order :0
Purity: ≥95%

Keywords

4-Thiazolecarboxylic acid, 5-[3-[4-(aminomethyl)phenoxy]propyl]-2-[8-[2-(2-benzothiazolyl)hydrazinylidene]-5,6,7,8-tetrahydro-2-naphthalenyl]- 5-[3-[4-(Aminomethyl)phenoxy]propyl]-2-[8-[2-(2-benzothiazolyl)hydrazinylidene]-5,6,7,8-tetrahydro-2-naphthalenyl]-4-thiazolecarboxylic acid

Quick Details

Appearance:Solid
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store in a cool and dry place and at 2-8°C for short term (days to weeks) or -20°C for long term (months to years)
Transportation:

Superiority:

We provide customized and high-quality WEHI-539 product for your project.

Details:

WEHI-539, a selective BCL-XL inhibitor that can be function as a single-agent inducer of apoptosis while sparing normal cells, it leads to MOMP and apoptosis due to displacing bound activator BH3s or monomeric BAX and BAK from BCL-XL to induce the homo-ol

View All